Blog

Quality FFPE analysis at single cell resolution: elevating single cell RNA sequencing innovation to the next level for optimized drug discovery and development Genomics Q² Solutions Quality FFPE analysis at single cell resolution: elevating single cell RNA sequencing innovation to the next level for optimized drug discovery and development
Authors: Joseph Modarelli, Adam Black and Douglas Wilson
Three key decisions cell and gene therapy trial sponsors need to make early into drug development Alan Wookey Three key decisions cell and gene therapy trial sponsors need to make early into drug development
In the rapidly growing and innovative therapeutic area, how do clinical trial sponsors effectively navigate the multitude of unique intricacies involved in cell and gene therapy development? In a...
Advances in Genomic Lab Services Drive Patient-Centered Clinical Trials Genomics David Latto, PhD Advances in Genomic Lab Services Drive Patient-Centered Clinical Trials
As pharmaceutical and biotech companies understand the value of cellular-level insights to further personalize patient care, advancements in genomic laboratory capabilities are growing in interest. ...
Cell therapy: devising a full clinical development plan Central Laboratories Alan Wookey Cell therapy: devising a full clinical development plan
Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails.Showcasing our IQVIA Connected...
Improving Pediatric R&D Success: Integrating the Younger Patient and Caregiver’s Perspective into Trial Design Central Laboratories Charlie Fix Improving Pediatric R&D Success: Integrating the Younger Patient and Caregiver’s Perspective into Trial Design
Given the multitude of nuances to consider when conducting a pediatric trail, it is vital that sponsor form a comprehensive strategy early in the trail design. Q2 Solutions' Charlie Fix along with...
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma Genomics Q² Solutions Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
Cell Reports article, with contributions from Martin Buchkovich, Q2 Solutions Genomics Highlights
Building a Greener Lab Q² Solutions Building a Greener Lab
Why a roadmap towards more sustainable science is essential to improve the environmental impact of pathology labs everywhere
Benefits of Digital Pathology for Clinical Trial Sponsors and Pathology Teams Digital Pathology Monika Lamba, MD, Ph.D. Benefits of Digital Pathology for Clinical Trial Sponsors and Pathology Teams
Can advances in tech-enabled solutions and workflows optimize diagnostic analysis while reducing the burden on pathologists?
At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ Device Central Laboratories virtual clinical trials Chuck Drucker At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ Device
Supporting virtual clinical trials with laboratory services that focus on easing patient and site burden by way of innovative self-collection technology.
What are the opportunities for decentralized clinical trials Central Laboratories Stephanie Larimer What are the opportunities for decentralized clinical trials
Hybrid and decentralized clinical trials (DCTs) are fast becoming the norm, but they often involve multiple vendors and service providers, presenting sponsors and CROs with new considerations on the...